Gehealthcare

GEHC | Continued stock growth - Timeframe: Weekly - Trade type: Buy stop order - Price: 71.92 - Take Profit: Open - Stop Loss: 68.84 (-4.30 %) Idea: Long on a breakout above last week's high - bullish momentum continuation. Entry: Buy stop above last week’s high. Stop-loss: Below the low of the same candle. If the weekly candle closes below this level, the trade is invalidated.

Bullish potential detected for GEHC Entry conditions: (i) higher share price for NASDAQ:GEHC along with swing up of indicators such as DMI/RSI, and (ii) observation of market reaction around the potential support/resistance line of $65.69 from the open of 10th June. Depending on risk tolerance, the stop loss for the trade would be: (i) below the recent potential support from the open of 11th May ($63.00), or (ii) below the recent swing low from mid-May ($60.67).

GE Healthcare Technology | GEHC | Long at $62.25 GE Healthcare Technology $NASDAQ:GEHC. An aging and unhealthy population will only create an increased need for healthcare imaging services. Add AI to the diagnostic mix, and imaging will be imperative for routine health maintenance and screening. With a P/E of 15x, debt-to equity of 1x, earnings forecast growth of 8.36% per year, and bullish analyst ratings, this could be a good value play for the patient. Thus, at $62.25, NASDAQ:GEHC is in a personal buy zone. Further drops are possible if

by WorthlessViews

GE HealthCare | GEHC GE Healthcare aka GEHC is a renowned global medical technology, pharmaceutical diagnostics, and digital solutions company that aims to revolutionize healthcare by eliminating limits. With a diverse portfolio of innovative products, services, and solutions, GEHC empowers healthcare professionals to make informed decisions quickly and improve patient care across the entire healthcare continuum. This article delves into the key aspects of GE Healthcare, including its business segments, macro trends

GE HealthCare Surpasses Expectations with Strong Q4 Performance General Electric's healthcare division (NASDAQ: NASDAQ:GEHC ), GE HealthCare, has emerged as a standout performer in the fourth quarter, exceeding both revenue and earnings estimates. Despite ongoing challenges in the global market, the company has demonstrated resilience and delivered robust financial results, much to the delight of investors and analysts alike. Earnings Overview GE HealthCare's (NASDAQ: NASDAQ:GEHC ) adjusted annual profit forecast of $4.20 to $4.35 per share signals a promis